Anti-Mouse CD8a In Vivo Antibody - Low Endotoxin (2.43) 供应商 BioXCell 产品货号 ICH1045 产品报价 ￥询价/5mg ￥25mg ￥50mg ￥100mg 产品说明书 点击查看 购买方式 该货号产品已停产,请在bioxcell查找更优的替代产品。 产品新闻 背景资料 BioXCell公司成立于1997年美国,具有25年以上单克隆抗体和重组蛋白...
上海玉博生物科技有限公司 主要致力于“anti-human CD8a Purified HIT8a 25 ug eBioscience-14-0089-80”的生产销售。多年的“anti-human CD8a Purified HIT8a 25 ug eBioscience-14-0089-80”生产与销售的经验,与各行业新老用户建立了稳定的合作关系,我公司经营的产品名
上海玉博生物科技有限公司 主要致力于“anti-human CD8a PE RPA-T8 25 ug eBioscience-12-0088-80”的生产销售。多年的“anti-human CD8a PE RPA-T8 25 ug eBioscience-12-0088-80”生产与销售的经验,与各行业新老用户建立了稳定的合作关系,我公司经营的产品名称深受广大
荷瘤前一天腹腔注射,以后每3天注射一次。 剂量: anti-mouse CD4[GK1.5,100ug],anti-mouseCD8a[YTS169.4,100ug],anti-mouse Ly6G[1A8,200ug] 【BioXCell】 3.DCs的节律性抗肿瘤反应 免疫荧光immunofluorescence imaging+定量成像quantitative imaging EdU、BrdU(CTV、CSFV?)检测细胞增殖情况: 代替胸腺嘧啶T 4.Con...
CD8+ T cells were depleted in a subset of mice by intraperitoneal injection of CD8a depletion antibody (BioXcell, 2.43 clone), 3 times per week at 150 μg per animal. Drugs were given for the duration of the study, and comparable control treated with vehicle or rat IgG2a isotype ...
Using single-cell RNA sequencing, we found that APG-2575 polarized M2-like immunosuppressive macrophages toward the M1-like immunostimulatory phenotype with increased CCL5 and CXCL10 secretion, restoring T-cell function and promoting a favorable immunotherapy response. Mechanistically, we demonstrated that...
CD8+ T cells were depleted in a subset of mice by intraperitoneal injection of CD8a depletion anti- body (BioXcell, 2.43 clone), 3 times per week at 150 μg per animal. Drugs were given for the duration of the study, and comparable control treated with vehicle or rat IgG2a isotype ...
a,b, Early T cell expansion (day +4) or persistence (day +11) after infusion of transduced T cells against WT leukemia (a; exact P value of <0.0001) and CD19lo leukemia (b; exact P value of <0.0001). Transduced T cell populations were measured by coexpression of CD8a+TCRβ+EGFR...
In contrast, the genes that were enriched in the R group primarily pertained to T cell activation (e.g., CD8A, CD8B, CD3D, GZMA, GZMB, TRAC, CST7), and NK cell activation (e.g., CD96, ITK, CD52) (Fig. 2d; Supplementary Table S3). Accordingly, GO analysis demonstrated that ...
Upon an average volume of 200 mm3, mice were randomized in different treatment groups: RT + PBS + IgG (LFT-2, BioXcell), RT + L19-IL2 + IgG, RT + PBS + aPD-L1 (10F.9G2, BioXcell), and RT + L19-IL2 + aPD-L1. Tumors were locally irradiated with 5 Gy (CT26) or 10 Gy ...